Neil Brewis, PhD., DSc
2021
In 2021, Neil Brewis, PhD., DSc earned a total compensation of $838.4K as Chief Scientific Officer at F-star Therapeutics, a 50% decrease compared to previous year.
Compensation breakdown
| Bonus | $107,821 |
|---|---|
| Option Awards | $126,793 |
| Salary | $412,685 |
| Stock Awards | $154,260 |
| Other | $36,857 |
| Total | $838,416 |
DSc received $412.7K in salary, accounting for 49% of the total pay in 2021.
DSc also received $107.8K in bonus, $126.8K in option awards, $154.3K in stock awards and $36.9K in other compensation.
Rankings
In 2021, Neil Brewis, PhD., DSc's compensation ranked 9,337th out of 12,405 executives tracked by ExecPay. In other words, DSc earned more than 24.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,337 out of 12,405 | 25th |
Division Manufacturing | 4,136 out of 5,494 | 25th |
Major group Chemicals And Allied Products | 1,823 out of 2,369 | 23rd |
Industry group Drugs | 1,617 out of 2,090 | 23rd |
Industry Pharmaceutical Preparations | 1,199 out of 1,537 | 22nd |
Source: SEC filing on April 22, 2022.
DSc's colleagues
We found three more compensation records of executives who worked with Neil Brewis, PhD., DSc at F-star Therapeutics in 2021.